Immediate Impact
68 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Lung cancer statistics, 2023
2024 Standout
Works of Michael Simoff being referenced
Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael Simoff | 402 | 53 | 6 | 184 | 147 | 12 | 452 | |
| Claire Taylor | 203 | 67 | 6 | 170 | 80 | 11 | 422 | |
| Victor Hsue | 259 | 49 | 3 | 78 | 234 | 16 | 416 | |
| Alfonso Illiano | 293 | 43 | 4 | 105 | 313 | 9 | 461 | |
| Cristina Maddau | 244 | 105 | 188 | 159 | 22 | 477 | ||
| Timothy Judge | 338 | 88 | 35 | 89 | 172 | 8 | 496 | |
| Timothy Craig Allen | 278 | 54 | 1 | 70 | 76 | 13 | 386 | |
| Gary Shelton | 337 | 32 | 93 | 194 | 14 | 466 | ||
| Pierre Ghosn | 322 | 106 | 65 | 86 | 122 | 10 | 507 | |
| Benjamin Ely | 223 | 117 | 16 | 196 | 229 | 9 | 504 | |
| Szu-Yun Leu | 147 | 143 | 1 | 100 | 220 | 9 | 433 |
All Works
Loading papers...